HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries

This Week in 340B: March 10 – March 16, 2026

Posted In 340B

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In a case brought by a 340B covered entity to challenge the Exclusion Rule, the defendant filed its response to the covered entity plaintiff’s motion for summary judgment.
  • In a case by a covered entity against a drug manufacturer alleging breach of contract, the court granted the covered entity’s motion to remand back to state court for lack of subject matter jurisdiction.
  • In a case brought by a drug manufacturer challenging a Tennessee state law governing contract pharmacy arrangements, the defendant filed a reply supporting review of the order denying a stay of discovery.
  • In a case brought by a trade association for drug manufacturers challenging an Oregon state law governing contract pharmacy arrangements, the defendants filed a reply supporting summary judgment.
  • In a case brought by a drug manufacturer challenging an Oregon state law governing contract pharmacy arrangements, the defendants filed a reply supporting summary judgment.
  • In a case brought by a drug manufacturer challenging a Rhode Island state law governing contract pharmacy arrangements, the defendants‑appellees filed a brief requesting affirmance of the denial of a preliminary injunction.
Emily Jane Cook
Emily Cook is a practice area leader for McDermott's Healthcare Regulatory & Compliance practice. She is a national authority on the 340B drug pricing program, and also helps clients navigate the full suite of federal and state regulations that are essential to healthcare operations. Learn more about Emily's practice here.


Matthew David
Matthew David focuses his practice on transactional and regulatory matters affecting a wide range of clients in the healthcare industry.Learn more about Matthew's practice here.


Abygail Hoey
Abygail Hoey is a member of the Health & Life Sciences Practice Group, where she focuses her practice on healthcare transactions, as well as regulatory and compliance matters. Learn more about Abygail's practice: https://www.mwe.com/people/abygail-hoey/


Margaret Houtz
Margaret (Maggie) Houtz is a member of the Healthcare Practice Group, where she works on a range of transactional and regulatory matters affecting the healthcare industry.Learn more about Maggie's practice here.


Kelsey Reinhardt
Kelsey R. Reinhardt focuses her practice on regulatory and transactional matters affecting a wide range of clients across the healthcare industry. Learn more about Kelsey's practice here.

STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
U.S. News Law Firm of the Year 2022 Health Care Law
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm